Food Limitations In Crohn's Disease and Ulcerative coliTis
FLIT
Förändrat Livsmedelsval Vid Inflammatorisk Tarmsjukdom
1 other identifier
interventional
140
1 country
1
Brief Summary
The goal of this clinical trial is to increase the knowledge on what type of diet affects inflammation and how to better convay that information in patients with inflammatory bowel disease (IBD) and decrease selective eating in patients with IBD. The main questions it aims to answer are:
- will the use of calprotectin as a control for changes in inflammation decrease selective food choices?
- will the use of a digital information tool increase quality of life (QoL) och decrease selctive eating patterns?
- will a diet based on nordic food choices decrease inflammation and increase QoL? Researchers will compare with IBD-patients in ordinary care. Participants will eat a test diet during six weeks or go through a digital information tool.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 19, 2025
CompletedFirst Posted
Study publicly available on registry
December 17, 2025
CompletedStudy Start
First participant enrolled
February 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2027
December 24, 2025
October 1, 2025
1.9 years
November 19, 2025
December 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentration of calproteictin
From enrollment until 6 weeks
Secondary Outcomes (1)
Four days registrered food intake
At beginning and after 6 week
Study Arms (4)
Normal diet
NO INTERVENTIONTest diet calprotectin
EXPERIMENTALTest diets Nordic
EXPERIMENTALDigital information tool
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- Ulcerative colitis and Crohn's disease
- Calprotectin 200-600
You may not qualify if:
- Non-active disease
- solely procitis
- Severe disease
- past extensive bowel surgery
- treatment with antibiotics (last month or present)
- pregnancy
- unability to understand spoken or written Swedish
- Multimorbidity which aggrevate participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Region Skanelead
Study Sites (1)
Mag- och tarmmottagningen, Skåne university hospital
Malmo, 20502, Sweden
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Although the patients know that they will be given dietary advice they will not know what type of intervention the other group will be offered. Since dietary advice must be given by the investigators the study cannot be blinded to them.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 19, 2025
First Posted
December 17, 2025
Study Start
February 1, 2026
Primary Completion (Estimated)
December 30, 2027
Study Completion (Estimated)
December 30, 2027
Last Updated
December 24, 2025
Record last verified: 2025-10
Data Sharing
- IPD Sharing
- Will not share